Diabetes Mellitus, Type 2
Showing 1 - 25 of 2,916
Blood Metabolic Markers in Type 2 Diabetes Mellitus of Different
Not yet recruiting
- Diabetes Mellitus, Type 2
- No intervention
-
Jinan, Shandong, ChinaPeng Wu
Nov 24, 2023
Glucose Metabolism Disorders, Diabetes, Type 2, Hypoglycemic Agents Trial in Karachi (Empagliflozin 10 MG,
Recruiting
- Glucose Metabolism Disorders
- +3 more
- Empagliflozin 10 MG
- Insulin+Metformin+DPP4 inhibitor (DPP4I)
-
Karachi, PakistanSINA Shireen Jinnah colony
Nov 28, 2023
Saudi Arabia to Understand How Dose Check App Used With Tresiba
Not yet recruiting
- Diabetes Mellitus, Type 2
- Insulin degludec
-
Al Khobar, Saudi Arabia
- +6 more
Nov 23, 2023
Diabetes, Type 2, Overweight or Obesity Trial (HIIT snacks, Sprint snacks, Control)
Not yet recruiting
- Diabetes Mellitus, Type 2
- Overweight or Obesity
- HIIT snacks
- +2 more
- (no location specified)
Nov 22, 2023
Diabetes, Type 2 Trial (NW Low-Glu®, Metformin)
Not yet recruiting
- Diabetes Mellitus, Type 2
- NW Low-Glu®
- Metformin
- (no location specified)
Nov 20, 2023
Diabetes, Type 2, Overweight and Obesity, Non-Alcoholic Fatty Liver Disease Trial (Dietary macronutrient composition)
Not yet recruiting
- Diabetes Mellitus, Type 2
- +3 more
- Dietary macronutrient composition
- (no location specified)
Nov 16, 2023
Diabetes, Type 2 Trial in Changchun (AP026 (TQA2226) for injection, AP026 (TQA2226) for injection matching )
Recruiting
- Diabetes Mellitus, Type 2
- AP026 (TQA2226) for injection
- AP026 (TQA2226) for injection matching placebo
-
Changchun, Jilin, ChinaThe first hospital of Jilin University
Nov 16, 2023
Diabetes, Type 2 Trial in Seoul (administration of UI068, administration of UIC202205, UIC202206)
Completed
- Diabetes Mellitus, Type 2
- administration of UI068
- administration of UIC202205, UIC202206
-
Seoul, Gwanak-gu, Korea, Republic ofH plus Yangji Hospital
Nov 15, 2023
Periodontitis, Diabetes, Type 2 Trial in Istanbul (Non-Surgical Periodontal Treatment)
Completed
- Periodontitis
- Diabetes Mellitus, Type 2
- Non-Surgical Periodontal Treatment
-
Istanbul, TurkeyMarmara University
Nov 11, 2023
Diabetes, Type 2 Trial in Cruz-Quebrada (HIIT)
Not yet recruiting
- Diabetes Mellitus, Type 2
- HIIT
-
Cruz-Quebrada, Oeiras, PortugalFaculdade de Motricidade Humana
Nov 15, 2023
Diabetes, Type 2 Trial (Telemonitoring 1, Telemonitoring 2)
Not yet recruiting
- Diabetes Mellitus, Type 2
- Telemonitoring 1
- Telemonitoring 2
- (no location specified)
Nov 14, 2023
Obesity, Liver Diseases, Liver Fibrosis Trial in Boston (ESG, GLP1-RA)
Not yet recruiting
- Obesity
- +16 more
- ESG
- GLP1-RA
-
Boston, MassachusettsBrigham and Women's Hospital
Nov 14, 2023
Diabetes, Type 2 Trial in Italy (Health promotion, Usual care)
Recruiting
- Diabetes Mellitus, Type 2
- Health promotion
- Usual care
-
Catanzaro, Italy
- +3 more
Nov 9, 2023
Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 50/500 mg extended release
Completed
- Bioequivalence
- Diabetes Mellitus, Type 2
- Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
-
San Pedro Garza García, Nuevo León, MexicoAvant Santé Research Center S.A. de C.V.
Nov 8, 2023
Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 100/1000 mg extended release
Completed
- Bioequivalence
- Diabetes Mellitus, Type 2
- Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet
-
San Pedro Garza García, Nuevo León, MexicoAvant Santé Research Center S.A. de C.V.
Nov 8, 2023
Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 100/1000 mg extended release
Completed
- Bioequivalence
- Diabetes Mellitus, Type 2
- Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet
-
San Pedro Garza García, Nuevo León, MexicoAvant Santé Research Center S.A. de C.V.
Nov 8, 2023
Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza Garcia (Sitagliptin/Metformin HCl 50/500 mg extended release
Completed
- Bioequivalence
- Diabetes Mellitus, Type 2
- Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
-
San Pedro Garza Garcia, Nuevo León, MexicoAvant Santé Research Center S.A. de C.V.
Nov 8, 2023
Diabetes, Type 2, Obesity, Prediabetic State Trial in Toronto (Early (7:00 - 16:00) TRE, Mid (9:30 - 18:30) TRE, Late (12:00 -
Not yet recruiting
- Diabetes Mellitus, Type 2
- +3 more
- Early (7:00 - 16:00) TRE
- +2 more
-
Toronto, Ontario, CanadaRemote Ontario-wide
Oct 31, 2023
Glucagon-like Peptide-1 Receptor Agonists According to Type 2
Recruiting
- Diabetes Mellitus, Type 2
- GLP-1 receptor agonist
-
Bari, ItalyAzienda Ospedaliero-Universitaria Policlinico Bari
Nov 4, 2023
Obesity, Diabetes, Type 2 Trial in Copenhagen (Large liquid meal, spinal catheter and venous line)
Recruiting
- Obesity
- Diabetes Mellitus, Type 2
- Large liquid meal, spinal catheter and venous line
-
Copenhagen, DenmarkDeparrtment of clinical pharmacology
Oct 30, 2023
Metabolic Syndrome, Complementary Therapies, Diabetes, Type 2 Trial (Fenobet, Placebo)
Not yet recruiting
- Metabolic Syndrome
- +2 more
- Fenobet
- Placebo
- (no location specified)
Nov 1, 2023
Diabetes, Type 2, Diabetes Type 2 in Obese Trial in Washington (low-fat vegan diet)
Not yet recruiting
- Diabetes Mellitus, Type 2
- Diabetes Mellitus Type 2 in Obese
- low-fat vegan diet
-
Washington, District of ColumbiaPhysicians Committee for Responsible Medicine
Oct 31, 2023
Diabetes, Type 2, PreDiabetes, Metabolic Syndrome Trial (The Cleerly CAD Staging System)
Not yet recruiting
- Diabetes Mellitus, Type 2
- +2 more
- The Cleerly CAD Staging System
- (no location specified)
Oct 31, 2023
Endothelial Function and Regenerative Cell Exhaustion
Not yet recruiting
- Diabetes Mellitus, Type 2
-
Scarborough, Ontario, CanadaDiagnostic Assessment Centre
Oct 25, 2023